Scott Alexander summarizes and responds to comments on his post about semaglutide, covering corrections, additional information, and user experiences with the weight loss drug. Longer summary

Scott Alexander summarizes and responds to comments on his previous post about semaglutide, a weight loss drug. The highlights include corrections to his original analysis, additional information on obtaining semaglutide cheaply, discussion of other weight loss drugs and treatments, challenges to Scott's predictions, debate over whether weight loss is maintained after stopping the drug, personal anecdotes from users, and mentions of some tangential debates in the comments. Shorter summary

Scott Alexander analyzes the economic and societal implications of semaglutide, a new effective weight loss drug, and its potential to reshape obesity treatment. Longer summary

Scott Alexander explores the economic and societal impact of semaglutide, a new weight loss drug. He discusses its effectiveness, current limited availability, and potential future widespread use. The post covers the drug's history, its current pricing and accessibility issues, and projections for its future market. Scott also touches on the broader implications for obesity treatment and the possibility of a 'post-obesity' future. Shorter summary